tiprankstipranks
Advertisement
Advertisement
Caris Life Sciences price target lowered to $28 from $35 at Citi
PremiumThe FlyCaris Life Sciences price target lowered to $28 from $35 at Citi
11d ago
Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31
Premium
Ratings
Analyst Reiterates Buy as Strong Revenue, Improving Profitability Offset Near-Term Risks; Price Target Trimmed to $31
11d ago
Caris Life Sciences Earnings Call Signals Profitable Surge
Premium
Company Announcements
Caris Life Sciences Earnings Call Signals Profitable Surge
11d ago
Caris Life Sciences initiated with a Neutral at Piper Sandler
PremiumThe FlyCaris Life Sciences initiated with a Neutral at Piper Sandler
1M ago
Caris Life Sciences price target lowered to $30 from $34 at Evercore ISI
Premium
The Fly
Caris Life Sciences price target lowered to $30 from $34 at Evercore ISI
1M ago
Caris Life Sciences launches Caris ChromoSeq tumor profiling assay
Premium
The Fly
Caris Life Sciences launches Caris ChromoSeq tumor profiling assay
2M ago
Caris Life Sciences price target lowered to $22 from $30 at Canaccord
PremiumThe FlyCaris Life Sciences price target lowered to $22 from $30 at Canaccord
2M ago
Caris Life Sciences Signals Strong Growth and Ambition
Premium
Company Announcements
Caris Life Sciences Signals Strong Growth and Ambition
2M ago
Caris Life Sciences price target raised to $28 from $26 at Baird
Premium
The Fly
Caris Life Sciences price target raised to $28 from $26 at Baird
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100